REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Johnson & Johnson, S.R.O. (Slovakia)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Johnson & Johnson, S.R.O. Profile Updated: October 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Johnson & Johnson, s.r.o. was founded in 1993 with headquarters in Bratislava. The company offers sale of optical lenses and also distribution of pharmaceutical products, health appliances and equipment.

Headquarters
Karadzicova, 12
Bratislava; Bratislavsky; Postal Code: 82108

Contact Details: Purchase the Johnson & Johnson, S.R.O. report to view the information.

Website: https://www.janssen.com/slovakia/

Basic Information
Total Employees:
Purchase the Johnson & Johnson, S.R.O. report to view the information.
Outstanding Shares:
Purchase the Johnson & Johnson, S.R.O. report to view the information.
Registered Capital:
Purchase the Johnson & Johnson, S.R.O. report to view the information.
Incorporation Date:
March 19, 1993
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Attorney
Purchase this report to view the information.
Attorney
Purchase this report to view the information.
Attorney
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Johnson & Johnson, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-2.39%▼
Total operating revenue
-21.47%▼
Operating profit (EBIT)
-88.28%▼
EBITDA
-86.69%▼
Net Profit (Loss) for the Period
-92.84%▼
Total assets
6.84%▲
Total equity
9.7%▲
Operating Profit Margin (ROS)
-12.41%▼
Net Profit Margin
-10.31%▼
Return on Equity (ROE)
-49.94%▼
Debt to Equity Ratio
0.05%▲
Quick Ratio
-0.06%▼
Cash Ratio
0.01%▲

Similar companies

Novartis Slovakia s.r.o.
 
Saneca Pharmaceuticals a. s.
HBM Pharma s.r.o.
 
Hartmann - Rico spol. s r.o.
BB Pharma s.r.o.
 
Unimed Pharma, spol. s r.o.
Biotika a.s.
 
Pharmagal - BIO, spol. s r.o.
Imuna Pharm, a.s.
 
Generica spol. s r.o.

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo